186 related articles for article (PubMed ID: 21184754)
1. PTD4-apoptin protein and dacarbazine show a synergistic antitumor effect on B16-F1 melanoma in vitro and in vivo.
Jin JL; Gong J; Yin TJ; Lu YJ; Xia JJ; Xie YY; Di Y; He L; Guo JL; Sun J; Noteborn MH; Qu S
Eur J Pharmacol; 2011 Mar; 654(1):17-25. PubMed ID: 21184754
[TBL] [Abstract][Full Text] [Related]
2. PTD4-apoptin protein therapy inhibits tumor growth in vivo.
Sun J; Yan Y; Wang XT; Liu XW; Peng DJ; Wang M; Tian J; Zong YQ; Zhang YH; Noteborn MH; Qu S
Int J Cancer; 2009 Jun; 124(12):2973-81. PubMed ID: 19326452
[TBL] [Abstract][Full Text] [Related]
3. Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model.
Wolf M; Eskerski H; Bauder-Wüst U; Haberkorn U; Eisenhut M
Melanoma Res; 2006 Dec; 16(6):487-96. PubMed ID: 17119449
[TBL] [Abstract][Full Text] [Related]
4. Apoptin towards safe and efficient anticancer therapies.
Backendorf C; Noteborn MH
Adv Exp Med Biol; 2014; 818():39-59. PubMed ID: 25001531
[TBL] [Abstract][Full Text] [Related]
5. B16 and cloudman S91 mouse melanoma cells susceptibility to apoptosis after dacarbazine treatment.
Olszewska-Słonina DM; Styczyńisk J; Drewa TA; Olszewski KJ; Czajkowski R
Acta Pol Pharm; 2005; 62(6):473-83. PubMed ID: 16583988
[TBL] [Abstract][Full Text] [Related]
6. PTD4-apoptin induces Bcl-2-insensitive apoptosis in human cervical carcinoma in vitro and in vivo.
Liu XW; Yuan P; Tian J; Li LJ; Wang Y; Huang SC; Liu L; Backendorf C; Noteborn MH; Sun J
Anticancer Drugs; 2016 Nov; 27(10):979-87. PubMed ID: 27548349
[TBL] [Abstract][Full Text] [Related]
7. Phenothiazines induce apoptosis in a B16 mouse melanoma cell line and attenuate in vivo melanoma tumor growth.
Gil-Ad I; Shtaif B; Levkovitz Y; Nordenberg J; Taler M; Korov I; Weizman A
Oncol Rep; 2006 Jan; 15(1):107-12. PubMed ID: 16328041
[TBL] [Abstract][Full Text] [Related]
8. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response.
Wack C; Kirst A; Becker JC; Lutz WK; Bröcker EB; Fischer WH
Cancer Immunol Immunother; 2002 Oct; 51(8):431-9. PubMed ID: 12202904
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferative activity of haloperidol in B16 mouse and human SK-MEL-28 melanoma cell lines.
Nordenberg J; Perlmutter I; Lavie G; Beery E; Uziel O; Morgenstern C; Fenig E; Weizman A
Int J Oncol; 2005 Oct; 27(4):1097-103. PubMed ID: 16142328
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
11. [The inhibitory effect of recombinant fibronectin polypeptide CH50 on the growth of B16 melanoma].
Zhang H; Feng Z; Zhang G
Zhonghua Zhong Liu Za Zhi; 1999 Nov; 21(6):416-8. PubMed ID: 11776614
[TBL] [Abstract][Full Text] [Related]
12. The in-vitro and in-vivo inhibitory activity of biflorin in melanoma.
Vasconcellos MC; Bezerra DP; Fonseca AM; Araújo AJ; Pessoa C; Lemos TL; Costa-Lotufo LV; de Moraes MO; Montenegro RC
Melanoma Res; 2011 Apr; 21(2):106-14. PubMed ID: 21346641
[TBL] [Abstract][Full Text] [Related]
13. [Construction of an angiostatin eukaryotic expression vector and characterization of its inhibitory efficiency in B16 melanoma bearing mice].
Wang JS; Sun DJ; Guo LH; Lin GW; Fei J
Shi Yan Sheng Wu Xue Bao; 2002 Dec; 35(4):303-6. PubMed ID: 15346988
[TBL] [Abstract][Full Text] [Related]
14. Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma.
Pierson HF; Meadows GG
Cancer Res; 1983 May; 43(5):2047-51. PubMed ID: 6831435
[TBL] [Abstract][Full Text] [Related]
15. Sequential chemoimmunotherapy with cisplatin, interferon-beta and interleukin-2 inhibits the growth of B16-F1 melanoma in syngeneic mice.
Kubo H; Matsumoto K; Funahashi M; Takagi H; Kitajima Y; Taniguchi S; Saida T
Melanoma Res; 2000 Jun; 10(3):223-9. PubMed ID: 10890375
[TBL] [Abstract][Full Text] [Related]
16. Nanoemulsion preparations of the anticancer drug dacarbazine significantly increase its efficacy in a xenograft mouse melanoma model.
Tagne JB; Kakumanu S; Nicolosi RJ
Mol Pharm; 2008; 5(6):1055-63. PubMed ID: 19434855
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth.
Brooks G; Wilson RE; Dooley TP; Goss MW; Hart IR
Cancer Res; 1991 Jun; 51(12):3281-8. PubMed ID: 2040003
[TBL] [Abstract][Full Text] [Related]
18. [Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
Zheng HQ; Liu DY
Ai Zheng; 2003 Apr; 22(4):363-7. PubMed ID: 12703989
[TBL] [Abstract][Full Text] [Related]
19. Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma.
Nakajima M; Hayashi K; Egi Y; Katayama K; Amano Y; Uehata M; Ohtsuki M; Fujii A; Oshita K; Kataoka H; Chiba K; Goto N; Kondo T
Cancer Chemother Pharmacol; 2003 Oct; 52(4):319-24. PubMed ID: 12783205
[TBL] [Abstract][Full Text] [Related]
20. The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.
Rouleau C; Menon K; Boutin P; Guyre C; Yoshida H; Kataoka S; Perricone M; Shankara S; Frankel AE; Duesbery NS; Vande Woude G; Biemann HP; Teicher BA
Int J Oncol; 2008 Apr; 32(4):739-48. PubMed ID: 18360701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]